These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 4139274

  • 21. Therapy with antibody-coated immune and hyperimmune peritoneal cells in a murine lymphoma system.
    Dullens HF, De Weger RA, Woutersen RA, Den Otter W.
    J Natl Cancer Inst; 1975 Jan; 54(1):77-82. PubMed ID: 1167595
    [Abstract] [Full Text] [Related]

  • 22. The nature of the effector cell in antibody-dependent, cell-mediated cytolysis (ADCC): the cytotoxic activity of murine tumor cells and peritoneal macrophages.
    Handwerger BS, Koren HS.
    Clin Immunol Immunopathol; 1976 Mar; 5(2):272-81. PubMed ID: 1277588
    [No Abstract] [Full Text] [Related]

  • 23. Tumour immunity in tetraparental mouse chimaeras--a review.
    Barnes RD.
    Eur J Cancer (1965); 1976 Apr; 12(4):283-90. PubMed ID: 60239
    [No Abstract] [Full Text] [Related]

  • 24. Immunotherapeutic suppression in transplantable solid tumours.
    Mizejewski GJ, Allen RP.
    Nature; 1974 Jul 05; 250(461):50-2. PubMed ID: 4135322
    [No Abstract] [Full Text] [Related]

  • 25. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF, Ceglowski WS, Friedman H.
    J Immunol; 1974 Jun 05; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract] [Full Text] [Related]

  • 26. Activated macrophages as cytotoxic effector cells. II. Requirement for local persistence of inducing antigen.
    Hibbs JB.
    Transplantation; 1975 Jan 05; 19(1):81-7. PubMed ID: 1091034
    [No Abstract] [Full Text] [Related]

  • 27. Immunogenicity of solubilized tumor antigen extracted from P1798 murine lymphoma cells or isolated from tumor-bearer ascites fluid and reactivity with anti-thy-1.2 antiserum.
    Gordon WC, Baechtel FS, Goetz G, Prager MD.
    Int J Cancer; 1977 May 15; 19(5):692-9. PubMed ID: 68017
    [Abstract] [Full Text] [Related]

  • 28. Increased binding of tumor cells by macrophages activated in vitro with lymphocyte mediators.
    Piessens WF.
    Cell Immunol; 1978 Feb 15; 35(2):303-17. PubMed ID: 202405
    [No Abstract] [Full Text] [Related]

  • 29. Nonspecific cytotoxicity of spleen cells and the specific cytotoxic action of thymus-derived lymphocytes in vitro.
    Grant CK, Alexander P.
    Cell Immunol; 1974 Oct 15; 14(1):46-51. PubMed ID: 4549557
    [No Abstract] [Full Text] [Related]

  • 30. [Immunity in transplantation of rat ascitic tumors in mice].
    Novikov DK, Adamenko GP, Novikova VI.
    Vopr Onkol; 1972 Oct 15; 18(7):77-81. PubMed ID: 4342629
    [No Abstract] [Full Text] [Related]

  • 31. Non-reactivity of incompatible lymphoid cells from f1 modified radiation chimeras to host tumour cells in vitro.
    Grant CK, Ilbery PL.
    Biomedicine; 1973 Feb 10; 19(2):56-60. PubMed ID: 4581503
    [No Abstract] [Full Text] [Related]

  • 32. Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.
    Bucana C, Hanna MG.
    J Natl Cancer Inst; 1974 Nov 10; 53(5):1313-23. PubMed ID: 4139279
    [No Abstract] [Full Text] [Related]

  • 33. [Study of the immunological response to hepatoma XXII in the inbred SZNA mice].
    Basmidzhian ME, Aleksanian IuT, Tat'ian MB.
    Zh Eksp Klin Med; 1974 Nov 10; 14(5):19-21. PubMed ID: 4376644
    [No Abstract] [Full Text] [Related]

  • 34. Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells.
    Bucana C, Hoyer LC, Hobbs B, Breesman S, McDaniel M, Hanna MG.
    Cancer Res; 1976 Dec 10; 36(12):4444-58. PubMed ID: 187323
    [Abstract] [Full Text] [Related]

  • 35. Identification of macrophage-mediated cytolytic activity as a tumor suppressive mechanism during maintenance of the L5178Y-tumor dormant state in DBA/2 mice.
    Robinson MK, Wheelock EF.
    J Immunol; 1981 Feb 10; 126(2):673-9. PubMed ID: 7451990
    [No Abstract] [Full Text] [Related]

  • 36. Immunochemical detection of tumor-specific and embryonic antigens of diethylnitrosamine-induced guinea pig tumors.
    Borsos T, Richardson AK, Ohanian SH, Leonard EJ.
    J Natl Cancer Inst; 1973 Dec 10; 51(6):1955-60. PubMed ID: 4128823
    [No Abstract] [Full Text] [Related]

  • 37. Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status.
    Baldwin RW, Embleton MJ, Robins RA.
    Int J Cancer; 1973 Jan 15; 11(1):1-10. PubMed ID: 4133609
    [No Abstract] [Full Text] [Related]

  • 38. Multiple in vitro mechanisms of tumor cytotoxicity demonstrated in the line-1 guinea pig hepatoma model.
    Osteen RT, Piessens WF, David JR, Churchill WH.
    J Natl Cancer Inst; 1975 Oct 15; 55(4):873-8. PubMed ID: 52720
    [Abstract] [Full Text] [Related]

  • 39. Immunization of rats against the Yoshida ascites hepatoma with viable cells injected subcutaneously or intramuscularly.
    Bellelli L, Nista A, Sezzi ML.
    Oncology; 1971 Oct 15; 25(3):249-57. PubMed ID: 4340708
    [No Abstract] [Full Text] [Related]

  • 40. Natural cytotoxic macrophages in the peritoneal cavity of mice.
    Pels E, Den Otter W.
    Br J Cancer; 1979 Dec 15; 40(6):856-61. PubMed ID: 526427
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.